Knygos.lt klubas Knygos.lt nariams
47,57 €
-35%
Įprastai
73,19 €
Adapting to Change
Adapting to Change
Knygos.lt klubas Knygos.lt nariams
47,57 €
-35%
Įprastai
73,19 €
  • Išsiųsime per 12–18 d.d.
The US pharmaceutical landscape is in the midst of impactful shifts. A series of ambitious, aggressive, and often interconnected federal policy changes--from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches--is creating a new reality for industry leaders, innovators, and strategists. In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies…
  • Leidėjas:
  • ISBN-10: 1041159803
  • ISBN-13: 9781041159803
  • Formatas: 14 x 21.6 x 0.7 cm, minkšti viršeliai
  • Kalba: Anglų

Adapting to Change (el. knyga) (skaityta knyga) | Molly Klote | knygos.lt

Atsiliepimai

Aprašymas

The US pharmaceutical landscape is in the midst of impactful shifts. A series of ambitious, aggressive, and often interconnected federal policy changes--from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches--is creating a new reality for industry leaders, innovators, and strategists.
In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered.

Knygos.lt klubas
Knygos.lt nariams
47,57 €
-35%
Įprastai
73,19 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 0,48 Knygų Eurų!?
Išsiųsime per 12–18 d.d.
Įsigykite dovanų kuponą
Daugiau
  • Autorius: Molly Klote
  • Leidėjas:
  • ISBN-10: 1041159803
  • ISBN-13: 9781041159803
  • Formatas: 14 x 21.6 x 0.7 cm, minkšti viršeliai
  • Kalba: Anglų

The US pharmaceutical landscape is in the midst of impactful shifts. A series of ambitious, aggressive, and often interconnected federal policy changes--from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches--is creating a new reality for industry leaders, innovators, and strategists.
In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)